Dr. Elgendy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
341 DEVANE STREET
Fayetteville, NC 28305Phone+1 438-378-2960Fax+1 910-218-8094
Summary
- Dr. Issa Elgendy is a pediatrician in Fayetteville, NC practice at Centre Universitaire De Santé McGill in Montréal, Québec,Canada. He is affiliated with Cape Fear Valley Medical Center. He received his medical degree from University of Alexandria Faculty of Medicine. He speaks English,French, Arabic and Swedish.He specialised in Paediatric Medicine , and is experience in Dermatology, Neonatology.
Education & Training
Cooper Medical School of Rowan University/Cooper University HospitalResidency, Pediatrics, 1990 - 1993
University of Alexandria Faculty of MedicineClass of 1978
Certifications & Licensure
NC State Medical License 1999 - 2026
FL State Medical License 2002 - 2008
MA State Medical License 1990 - 2006
GA State Medical License 1997 - 1999
NJ State Medical License 1991 - 1999- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Diplomat American Board of Pediatrics
Research History
- Principal Clinical InvestigatorAstella -Fujisawa Pharmaceuticals, longitudinal multinational study on use of topical immune modulator (Tacrolimus) Protopic Ointment 0.03% for treatment of Atopic Dermatitis in children aged 2-16 years old.2007 - 2018
- Principal Clinical InvestigatorAlcon Pharmaceuticals , Advisory Board member on use of Vigamox Ophthalmic Drops , Ciprodex Ottis Drops for treatment of acute Muco-Purulent and Otitis External in children.2006 - 2007
- Principal Clinical InvestigatorMerck Pharmaceuticals, Advisory Board Member on use of immune modulator Singulair(Montelukast Sodium) for treatment of Asthmatic Bronchitis and Allergic Rhinitis in children.2002 - 2003
- Principal Clinical InvestigatorRoche Pharmaceuticals, clinical investigator on a single blind randomized comparative clinical trial of single dose IM Ceftriaxone vs Benzathin Penicillin G. ( IM) for the treatment of Streptococcal Pharyngitis in children aged 2-12 years old.1994 - 1995
Professional Memberships
- Fellow
Other Languages
- Arabic, French, Swedish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
